These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35174954)

  • 1. Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [
    Mecca AP; O'Dell RS; Sharp ES; Banks ER; Bartlett HH; Zhao W; Lipior S; Diepenbrock NG; Chen MK; Naganawa M; Toyonaga T; Nabulsi NB; Vander Wyk BC; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Alzheimers Dement; 2022 Dec; 18(12):2527-2536. PubMed ID: 35174954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Nabulsi NB; Wyk BCV; Varma P; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Alzheimers Dement; 2020 Jul; 16(7):974-982. PubMed ID: 32400950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [
    O'Dell RS; Mecca AP; Chen MK; Naganawa M; Toyonaga T; Lu Y; Godek TA; Harris JE; Bartlett HH; Banks ER; Kominek VL; Zhao W; Nabulsi NB; Ropchan J; Ye Y; Vander Wyk BC; Huang Y; Arnsten AFT; Carson RE; van Dyck CH
    Alzheimers Res Ther; 2021 Jan; 13(1):11. PubMed ID: 33402201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET.
    Silva-Rudberg JA; Salardini E; O'Dell RS; Chen MK; Ra J; Georgelos JK; Morehouse MR; Melino KP; Varma P; Toyonaga T; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP
    Am J Geriatr Psychiatry; 2024 Jan; 32(1):17-28. PubMed ID: 37673749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principal component analysis of synaptic density measured with [
    O'Dell RS; Higgins-Chen A; Gupta D; Chen MK; Naganawa M; Toyonaga T; Lu Y; Ni G; Chupak A; Zhao W; Salardini E; Nabulsi NB; Huang Y; Arnsten AFT; Carson RE; van Dyck CH; Mecca AP
    Neuroimage Clin; 2023; 39():103457. PubMed ID: 37422964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.
    Kumar A; Scarpa M; Nordberg A
    Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography.
    Bastin C; Bahri MA; Meyer F; Manard M; Delhaye E; Plenevaux A; Becker G; Seret A; Mella C; Giacomelli F; Degueldre C; Balteau E; Luxen A; Salmon E
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):390-402. PubMed ID: 31468182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
    Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
    Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The associations between synaptic density and "A/T/N" biomarkers in Alzheimer's disease: An
    Li J; Huang Q; Qi N; He K; Li S; Huang L; Pan F; Ren S; Hua F; Huang Y; Guan Y; Guo Q; Zhao J; Xie F
    J Cereb Blood Flow Metab; 2024 Jul; 44(7):1199-1207. PubMed ID: 38295871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Synaptic Density Imaging with
    Toyonaga T; Smith LM; Finnema SJ; Gallezot JD; Naganawa M; Bini J; Mulnix T; Cai Z; Ropchan J; Huang Y; Strittmatter SM; Carson RE
    J Nucl Med; 2019 Dec; 60(12):1780-1786. PubMed ID: 31101744
    [No Abstract]   [Full Text] [Related]  

  • 12. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [
    Toyonaga T; Khattar N; Wu Y; Lu Y; Naganawa M; Gallezot JD; Matuskey D; Mecca AP; Pittman B; Dias M; Nabulsi NB; Finnema SJ; Chen MK; Arnsten A; Radhakrishnan R; Skosnik PD; D'Souza DC; Esterlis I; Huang Y; van Dyck CH; Carson RE
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1012-1022. PubMed ID: 37955791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of synaptic density with [
    Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
    Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
    Wang J; Huang Q; He K; Li J; Guo T; Yang Y; Lin Z; Li S; Vanderlinden G; Huang Y; Van Laere K; Guan Y; Guo Q; Ni R; Li B; Xie F
    Alzheimers Dement; 2024 Jun; 20(6):3876-3888. PubMed ID: 38634334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [
    Chen MK; Mecca AP; Naganawa M; Gallezot JD; Toyonaga T; Mondal J; Finnema SJ; Lin SF; O'Dell RS; McDonald JW; Michalak HR; Vander Wyk B; Nabulsi NB; Huang Y; Arnsten AF; van Dyck CH; Carson RE
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2395-2409. PubMed ID: 33757318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Synaptic Loss in β-Amyloid Positive Versus β-Amyloid Negative Corticobasal Syndrome.
    Holland N; Savulich G; Jones PS; Whiteside DJ; Street D; Swann P; Naessens M; Malpetti M; Hong YT; Fryer TD; Rittman T; Mulroy E; Aigbirhio FI; Bhatia KP; O'Brien JT; Rowe JB
    Mov Disord; 2024 Jul; 39(7):1166-1178. PubMed ID: 38671545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Banks ER; Ni GS; Rogers K; Gallezot JD; Ropchan J; Emery PR; Nabulsi NB; Vander Wyk BC; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Neurobiol Aging; 2022 Mar; 111():44-53. PubMed ID: 34963063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial volume correction analysis for
    Lu Y; Toyonaga T; Naganawa M; Gallezot JD; Chen MK; Mecca AP; van Dyck CH; Carson RE
    Neuroimage; 2021 Sep; 238():118248. PubMed ID: 34119639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.
    Salardini E; O'Dell RS; Tchorz E; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.